Trials / Unknown
UnknownNCT01921192
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- University of Catania · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated with extracellular matrix changes. Many studies demonstrated that high levels of this aminoacid in diabetic patients increases significantly the risk of the development of this pathology. This study has been undertaken to investigate the role of homocysteine and its cofactors (folic acid, vitamin B6 and B12) during the progression of the diabetic retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Folic Acid, vit B6 and B12 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-07-01
- First posted
- 2013-08-13
- Last updated
- 2013-08-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01921192. Inclusion in this directory is not an endorsement.